Meridian Bioscience ROE 2006-2018 | VIVO

Current and historical return on equity (ROE) values for Meridian Bioscience (VIVO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Meridian Bioscience ROE for the three months ending December 31, 2018 was 19.17%.
Meridian Bioscience ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.03B $0.18B 14.22%
2018-09-30 $0.02B $0.18B 13.20%
2018-06-30 $0.02B $0.18B 13.87%
2018-03-31 $0.02B $0.17B 9.93%
2017-12-31 $0.02B $0.17B 12.32%
2017-09-30 $0.02B $0.17B 12.44%
2017-06-30 $0.02B $0.17B 11.92%
2017-03-31 $0.03B $0.17B 17.26%
2016-12-31 $0.03B $0.17B 17.29%
2016-09-30 $0.03B $0.17B 18.99%
2016-06-30 $0.04B $0.17B 20.77%
2016-03-31 $0.04B $0.17B 20.93%
2015-12-31 $0.04B $0.17B 21.82%
2015-09-30 $0.04B $0.17B 21.47%
2015-06-30 $0.04B $0.16B 21.64%
2015-03-31 $0.04B $0.16B 21.71%
2014-12-31 $0.04B $0.16B 21.74%
2014-09-30 $0.03B $0.16B 21.25%
2014-06-30 $0.04B $0.16B 22.08%
2014-03-31 $0.04B $0.16B 23.11%
2013-12-31 $0.04B $0.16B 23.57%
2013-09-30 $0.04B $0.16B 25.00%
2013-06-30 $0.04B $0.15B 25.52%
2013-03-31 $0.04B $0.15B 25.26%
2012-12-31 $0.04B $0.14B 25.58%
2012-09-30 $0.04B $0.14B 24.87%
2012-06-30 $0.03B $0.14B 23.61%
2012-03-31 $0.03B $0.14B 22.30%
2011-12-31 $0.03B $0.14B 20.25%
2011-09-30 $0.03B $0.14B 19.57%
2011-06-30 $0.03B $0.14B 18.18%
2011-03-31 $0.02B $0.14B 17.49%
2010-12-31 $0.02B $0.14B 16.73%
2010-09-30 $0.03B $0.14B 18.81%
2010-06-30 $0.03B $0.14B 21.66%
2010-03-31 $0.03B $0.14B 23.91%
2009-12-31 $0.03B $0.14B 24.95%
2009-09-30 $0.03B $0.14B 24.63%
2009-06-30 $0.03B $0.14B 24.33%
2009-03-31 $0.03B $0.13B 24.08%
2008-12-31 $0.03B $0.13B 24.55%
2008-09-30 $0.03B $0.13B 24.44%
2008-06-30 $0.03B $0.12B 23.53%
2008-03-31 $0.03B $0.12B 25.16%
2007-12-31 $0.03B $0.12B 25.34%
2007-09-30 $0.03B $0.11B 25.53%
2007-06-30 $0.03B $0.11B 25.74%
2007-03-31 $0.02B $0.10B 22.74%
2006-12-31 $0.02B $0.10B 22.52%
2006-09-30 $0.02B $0.09B 20.99%
2006-06-30 $0.02B $0.09B 20.45%
2006-03-31 $0.02B $0.09B 20.71%
2005-12-31 $0.01B $0.09B 21.13%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.531B $0.214B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
HEXO (HEXO) $1.424B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71